CLINICAL TRIALS PROFILE FOR PREDNICARBATE
✉ Email this page to a colleague
All Clinical Trials for prednicarbate
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00261079 ↗ | Fexofenadine in Pruritic Skin Disease | Completed | Handok Inc. | Phase 4 | 2005-04-01 | Primary objective: - To compare the efficacy and safety profile of Fexofenadine 180mg tablets plus prednicarbate(2.5mg/g) vs prednicarbate(2.5mg/g) alone in the treatment of pruritic skin disease Secondary objective: - To evaluate patient's satisfaction of Allegra treatment |
NCT00261079 ↗ | Fexofenadine in Pruritic Skin Disease | Completed | Handok Pharmaceuticals Co., Ltd. | Phase 4 | 2005-04-01 | Primary objective: - To compare the efficacy and safety profile of Fexofenadine 180mg tablets plus prednicarbate(2.5mg/g) vs prednicarbate(2.5mg/g) alone in the treatment of pruritic skin disease Secondary objective: - To evaluate patient's satisfaction of Allegra treatment |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for prednicarbate
Condition Name
Clinical Trial Locations for prednicarbate
Clinical Trial Progress for prednicarbate
Clinical Trial Phase
Clinical Trial Sponsors for prednicarbate
Sponsor Name